Growing community of inventors

Kyoto, Japan

Ken-ichi Nishimura

Average Co-Inventor Count = 3.08

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 177

Ken-ichi NishimuraKazuhiko Kitao (3 patents)Ken-ichi NishimuraNobuharu Kakeya (3 patents)Ken-ichi NishimuraMasayasu Kasai (1 patent)Ken-ichi NishimuraAkihisa Yoshimi (1 patent)Ken-ichi NishimuraMasahiro Kikuchi (1 patent)Ken-ichi NishimuraKoichi Yamanouchi (1 patent)Ken-ichi NishimuraTakeshi Uchida (1 patent)Ken-ichi NishimuraSusumu Nishizawa (1 patent)Ken-ichi NishimuraNobuo Kondoh (1 patent)Ken-ichi NishimuraTakayoshi Mori (1 patent)Ken-ichi NishimuraSatoru Hatano (1 patent)Ken-ichi NishimuraHiroyuki Muro (1 patent)Ken-ichi NishimuraKen-ichi Nishimura (5 patents)Kazuhiko KitaoKazuhiko Kitao (7 patents)Nobuharu KakeyaNobuharu Kakeya (6 patents)Masayasu KasaiMasayasu Kasai (11 patents)Akihisa YoshimiAkihisa Yoshimi (8 patents)Masahiro KikuchiMasahiro Kikuchi (7 patents)Koichi YamanouchiKoichi Yamanouchi (6 patents)Takeshi UchidaTakeshi Uchida (5 patents)Susumu NishizawaSusumu Nishizawa (4 patents)Nobuo KondohNobuo Kondoh (3 patents)Takayoshi MoriTakayoshi Mori (2 patents)Satoru HatanoSatoru Hatano (2 patents)Hiroyuki MuroHiroyuki Muro (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Kyoto Yakuhin Kogyo Kabushiki Kaisha (3 from 4 patents)

2. Kyoto Pharmaceutical Industries, Ltd. (2 from 26 patents)

3. The Green Cross Corporation (1 from 260 patents)


5 patents:

1. 5491171 - Pharmaceutical preparation containing prostaglandin compound for rectal

2. 5389625 - Cephalosporin compounds

3. 4485033 - Adjuvant for promoting absorption of pharmacologically active substances

4. 4442090 - Absorption-promoting compounds, compositions thereof with

5. 4338306 - Adjuvant for promoting absorption of pharmacologically active substances

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/30/2025
Loading…